Drug Pricing Negotiations: A Biden Accomplishment Amidst Lobbyist Challenges

This chapter explores Joe Biden's strategy to negotiate prescription drug prices through government intervention, contextualizing it within decades of Democratic efforts. It examines the impact of the pharmaceutical lobby and highlights a notable legislative achievement in Medicare drug price negotiations, while contrasting Biden's tangible successes with potential superficial claims by Trump.